Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy

Journal of Medicinal Chemistry

Volumn 43, Issue 11, 2000, Pages 2093-2099

  Mayer, Moriz ^a   Meyer, Bernd ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BINDING AFFINITY; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; HYPERTENSION; LIGAND BINDING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CAPTOPRIL; DIPEPTIDES; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDYL-DIPEPTIDASE A; RABBITS;

EID: 0034212746     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990194x     Document Type: Article

References (32)

1. Beckner, C. F.; Caprioli, R. M. Proteolytic activity of dipeptidyl carboxypeptidase from human lung. Biochem. Biophys. Res. Commun. 1980, 93, 1290-1296.
2. Skeggs, L. T.; Marsh, W. H.; Kahn, J. R.; Shumway, N. P. J. Exp. Med. 1954, 99, 275-282.
3. Erdös, E. G. Conversion of angiotensin I to angiotensin II. Am. J. Med. 1976, 60, 749-759.
4. Peach, M. J. Renin-angiotensin system: Biochemistry and mechanism of action. Physiol. Rev. 1977, 57, 313-370.
5. Mancini, G. B. Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease. Am. J. Med. 1998, 105, 40-47.
6. Brown, N. J.; Vaughan, D. E. Angiotensin-converting enzyme inhibitors. Circulation 1998, 97, 1411-1420.
7. Ondetti, M. A.; Rubin, B.; Cushman, D. W. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 1977, 796, 441-444.
8. Cushman, D. W.; Cheung, H. S.; Sabo, E. F.; Ondetti, M. A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 1977, 16, 5484-5491.
9. Pascard, C.; Guilhem, J.; Vincent, M.; Remond, G.; Portevin, B.; Laubie, M. Configuration and preferential solid-state conformations of perindoprilat (S-9780). Comparison with the crystal structures of other ACE inhibitors and conclusions related to structure - activity relationships. J. Med. Chem. 1991, 34, 663-669.
10. Hausin, R. J.; Codding, P. W. Cristallographic studies of angiotensin-converting enzyme inhibitors and analysis of preferred zinc coordination geometry. J. Med. Chem. 1990, 33, 1940-1947.
11. Coric, P.; Turcaud, S.; Meudal, H.; Roques, B. P.; Fournier-Zaluski, M.-C. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors. J. Med. Chem. 1996, 39, 1210-1219.
12. Fournier-Zaluski, M.-C.; Coric, P.; Thery, V.; Gonzales, W.; Meudal, H.; Turcaud, S.; Michel, J.-B.; Roques, B. P. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action. J. Med. Chem. 1996, 39, 2594-2608.
13. Meyer, B.; Weimar, T.; Peters T. Screening mixtures for biological activity by NMR. Eur. J. Biochem. 1997, 246, 705-709; Ger. Pat. 19649359.
14. Henrichsen, D.; Ernst, B.; Magnani, J. L.; Wang, W. T.; Meyer, B.; Peters T. Bioaffinity NMR spectroscopy: Identification of an E-Selectin antagonist in a substance mixture by transfer NOE. Angew. Chem., Int. Ed. 1999, 38, 98-102.
15. Fesik, S. W. NMR studies of molecular complexes as a tool in drug design. J. Med. Chem. 1991, 34, 2937-2945.
16. Holmquist, B.; Bünning, P.; Riordan, J. F. A continuous spectrophotometric assay for angiotensin-converting enzyme. Anal. Biochem. 1979, 95, 540-548.
17. Bünning, P.; Holmquist, B.; Riordan, J. F. Substrate specificity and kinetic characteristics of angiotensin-converting enzyme. Biochemistry 1983, 22, 103-110.
18. Behling, R. W.; Yamane, T.; Navon, G.; Sammon, M. J.; Jelinski, L. W. Measuring relative acetylcholine receptor agonist binding by selective proton nuclear magnetic resonance relaxation experiments. Biophys. J. 1988, 53, 947-954.
19. Lanir, A.; Navon, G. Nuclear magnetic resonance studies of bovine carbonic anhydrase. Binding of sulfonamides to the zinc enzyme. Biochemistry 1971, 10, 1024-1032.
20. Ni, F. Recent developments in transferred NOE methods. Prog. Nucl. Magn. Reson. Spectrose. 1994, 26, 517-606.
21. Clore, G. M.; Gronenborn, A. M. Theory and applications of the transferred nuclear Overhauser effect to the study of the conformations of small ligands bound to proteins. J. Magn. Reson. 1982, 48, 402-417.
22. Clore, G. M.; Gronenborn, A. M. Theory of the time dependent transferred nuclear Overhauser effect: Applications to structural analysis of ligand-protein complexes in solution. J. Magn. Reson. 1983, 53, 423-442.
23. Campbell, A. P.; Sykes, B. D. Theoretical evaluation of the two-dimensional transferred nuclear Overhauser effect. J. Magn. Reson. 1991, 93, 77-92.
24. Lian, L.-Y.; Barsukov, I. L.; Sutcliffe, M. J.; Sze, K. H.; Roberts, G. C. K. Protein ligand interactions-exchange processes and determination of ligand conformation and protein ligand contacts. Methods Enzymol. 1994, 239, 657-700.
25. Barsukov, I. L.; Lian, L.-Y.; Ellis, J.; Sze, K. H.; Shaw, W. V.; Roberts, G. C. K. The conformation of coenzyme A bound to chloramphenicol acetyltransferase determined by transferred NOE experiments. J. Mol. Biol. 1996, 262, 543-558.
26. Patchett, A. A.; Harris, E.; Tristram, E. W.; Wyvratt, M. J.; Wu, M. T.; Taub, D.; Peterson, E. R.; Ikeler, T. J.; ten Broeke, J.; Payne, L. G.; Ondeyka, D. L.; Thorsett, E. D.; Greenlee, W. J.; Lohr, N. S.; Hoffsommer, R. D.; Joshua, H.; Ruyle, W. V.; Rothrock, J. W.; Aster, S. D.; Maycock, A. L.; Robinson, F. M.; Hirschmann, R.; Sweet, C. S.; Ulm, E. H.; Gross, D. M.; Vassil, T. C.; Stone, C. A. A new class of angiotensin-converting enzyme inhibitors. Nature 1980, 288, 280-283.
27. Patchett, A. A.; Cordes, E. H. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme. Adv. Enzymol. Relat. Areas Mol. Biol 1985, 57, 1-84.
28. Grobelyn, D.; Galardy, R. E. Inhibition of angiotensin-converting enzyme by aldehyde and ketone substrate analogues. Biochemistry 1986, 25, 1072-1078.
29. Almquist, R. G.; Chao, W.-R.; Ellis, M. E.; Johnson, H. L. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin-converting enzyme. J. Med. Chem. 1980, 23, 1392-1398.
30. Strittmatter, S. M.; Snyder, S. H. Characterization of angiotensin-converting enzyme by [3H] captopril binding. Mol. Pharmacol. 1986, 29, 142-148.
31. Das. M.; Soffer, R. Pulmonary angiotensin-converting enzyme. J. Biol. Chem. 1975, 250, 6762-6768.
32. 0 fields. J. Magn. Reson. Series A 1993, 705, 167-183.